Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Lachman Practice Groups

    Three Practices
    Executing One Vision

    Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus.

    Lachman OnCall Logo

    Get the answers and guidance to your most pressing questions faster than ever before.

    Now you can speak to one of our Subject Matter Experts and get the answers you need quickly on the many pressing issues arising in the life science areas that Lachman Consultants serves on a day to day basis. Whether it’s something you need to know about compliance, or a complex scientific or technical issue, Lachman OnCall™️ can provide you the timely information you require as needs arise and unforeseen questions occur.

    Learn More About Lachman OnCall

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Revisions to Nine ICH Veterinary Guidance Documents on Effectiveness of Anthelmintics

    While most of us were sleeping, the ICH has been busy revising nine of...
    Read More

    Official ANDA Approval Numbers, CRLs, and Original New ANDA receipts for July 2022 Reported

    July looks like another good month for OGD approval actions with a rep...
    Read More

    Data Integrity Series: Episode 2

    Traditionally, data integrity programs have focused on electronic syst...
    Read More

    More Nitrosamine Problems

    Today, the FDA advised that it “recently became aware of a nitrosami...
    Read More

    California Does It Again, Beware!

    Many in the pharmaceutical industry that do business or have products ...
    Read More

    Unofficial ANDA Approval Actions for July 2022

    With a flurry of approvals at the end of the month, the unofficial cou...
    Read More
    Contact Us Today